Last reviewed · How we verify
NCT03864991: LSHBA1C
Lifestyle Changes and Glycemic Control in T1D
NA trial testing e-device for step count (fit-bit) in Type1 Diabetes Mellitus in 120 participants. Status unknown.
30 November 2019
Quick facts
| Lead sponsor | Aga Khan University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | other |
| Enrollment | 120 |
| Start date | 29 October 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- e-device for step count (fit-bit)
- e-messages for log book
- e-messages for log book & fit-bit
Conditions studied
- Type1 Diabetes Mellitus — all drugs for Type1 Diabetes Mellitus →
- Life Style — all drugs for Life Style →
- Behavioral Changes — all drugs for Behavioral Changes →
- Self-Management — all drugs for Self-Management →
Sponsor
Aga Khan University
Who can join
15 and older, any sex, with Type1 Diabetes Mellitus or Life Style. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pakistani studies report non-adherence to self-management by type 1 diabetes (T1D) patients, and episodes of hypoglycemia and ketoacidosis as acute complications. Self-management guidelines include maintenance of logbooks for blood glucose, physical activity, and dietary intake, that affect glycated hemoglobin (HbA1C) and acute complications. The proposed study will evaluate whether mobile messaging for maintaining log books for blood glucose or e-device use for step count will modify HbA1c levels to be examined at three and six months after enrollment. In addition, episodes of acute complications and blood glucose variability will be correlated with daily log book maintenance and step counts.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach.
Sawani S, Siddiqui AR, Azam SI, Humayun K, et al · · 2020 · cited 1× · PMID 32312302 · DOI 10.1186/s13063-020-4205-7
Verify or expand the search:
- PubMed search for NCT03864991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type1 Diabetes Mellitus
Currently open trials in the same condition.
- NCT03945747 — MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus · active not recruiting
- NCT03369821 — EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) · recruiting
- NCT03811470 — China Diabetes Registry by Metabolic Management Center · recruiting
Other Aga Khan University trials
Trials by the same sponsor.
- NCT07475793 — Image Guided Genicular Nerve Radiofrequency Ablation for Chronic Knee Osteoarthritis · NA · not yet recruiting
- NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
- NCT07356063 — Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA · NA · not yet recruiting
- NCT07451951 — Effectiveness of SQLNS vs MQLNS for Prevention of Undernutrition in Children 6-12 Months · NA · not yet recruiting
- NCT07357350 — Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03864991 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aga Khan University
- Last refreshed: 6 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03864991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing